Back
Check Point Software Technologies Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Sell
49
CHKP
Check Point Software Technologies
Last Price:
$223.41
Seasonality Move:
3.47%
Buy
57
MLTX
MoonLake Immunotherapeutics
Last Price:
$56.63
Seasonality Move:
12.1%
Sell
49
Check Point Software Technologies (CHKP)
is a Sell
Is Check Point Software Technologies a Buy, Sell or Hold?
-
The current Check Point Software Technologies [CHKP] share price is $222.89. The Score for CHKP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
CHKP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
-
The current MoonLake Immunotherapeutics [MLTX] share price is $53.57. The Score for MLTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
MLTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHKP Stock Price Chart
What is Check Point Software Technologies's stock price today?
-
The Check Point Software Technologies share price today is $222.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHKP is experiencing slight selling pressure.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $53.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight buying pressure.
CHKP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 59.28 | Buy |
Relative Strength Index (14 RSI): | 52.37 | Buy |
Chaikin Money Flow: | -85691 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (217.1 - 223.9) | Buy |
Bollinger Bands (100): | (215.21 - 227.51) | Buy |
MLTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 14.36 | Buy |
Relative Strength Index (14 RSI): | 68.35 | Buy |
Chaikin Money Flow: | 48187 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.88 - 51.46) | Buy |
Bollinger Bands (100): | (37.05 - 46.75) | Buy |
CHKP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 218.94 | Buy |
20-day SMA: | 220.61 | Buy |
50-day SMA: | 222.24 | Buy |
200-day SMA: | 207.32 | Buy |
8-day EMA: | 206.4 | Buy |
20-day EMA: | 147.14 | Buy |
50-day EMA: | 78.57 | Buy |
200-day EMA: | 23.01 | Buy |
MLTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.06 | Buy |
20-day SMA: | 49.32 | Buy |
50-day SMA: | 44.91 | Buy |
200-day SMA: | 45.51 | Buy |
8-day EMA: | 49.17 | Buy |
20-day EMA: | 34.47 | Buy |
50-day EMA: | 18.24 | Buy |
200-day EMA: | 5.31 | Buy |
Check Point Software Technologies Earnings Growth & CHKP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.14 per share, an increase this year of $0.80 per share, and an increase next year of $0.90 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.20 per share, and a decrease next year of $0.62 per share.
Check Point Software Technologies Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
MoonLake Immunotherapeutics Technical Analysis
Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |